Dermata Therapeutics, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $5.5M
- Price
- $1.12
- % Change (Daily % change from the live per-ticker quote feed.)
- -0.88%
- Volume
- 7.4K
About
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Quick stats
Shares outstanding5.0M
Computed float3.1M
Float / shares63.2%
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001853816
Websitehttps://www.dermatarx.com
AI Summary
AI-generated1/14
standardbullishproduct launch
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment
Dermata Therapeutics announced the commercial launch of its first product, the Tome Foundational Treatment, which is now available for purchase on the company's website.
This launch signifies Dermata's strategic transition from a pre-commercial phase to a revenue-generating direct-to-consumer skincare company utilizing its proprietary Bioneedle technology.
Management stated that its focus will now shift to building brand awareness and driving consumer adoption as it looks to expand its portfolio of skincare offerings.